Lupinisoflavone M



Compound IDCDAMM02420
Common nameLupinisoflavone M
IUPAC name6-(2,3-dihydroxy-3-methylbutyl)-5,7-dihydroxy-3-[2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]chromen-4-one
Molecular formulaC25H28O8

Experimental data

Retention time7.77
Adduct[M+H]+
Actual mz457.185
Theoretical mz457.185
Error1.26
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.0393

Identifiers and class information

Inchi keyIXEGNYHOJYAEHW-UHFFFAOYNA-N
SmilesO=C1C(=COC2=CC(O)=C(C(O)=C12)CC(O)C(O)(C)C)C=3C=CC=4OC(CC4C3)C(O)(C)C
SuperclassPhenylpropanoids and polyketides
ClassIsoflavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)10
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)456.491
Computed dipole moment(dipole)3.443
Total solvent accessible surface area (SASA)756.291
Hydrophobic component of SASA (FOSA)354.459
Hydrophilic component of SASA (FISA)195.992
Pie component of the SASA (PISA)205.839
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1374.44
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)6.95
Free energy of solvation of dipole (dip^2/V)0.0086252
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0183792
Globularity descriptor (glob)0.790484
Predicted polarizability in cubic angstroms (QPpolrz)44.396
Predicted hexadecane/gas partition coefficient (QPlogPC16)14.81
Predicted octanol/gas partition coefficient (QPlogPoct)24.401
Predicted water/gas partition coefficient (QPlogPw)14.771
Predicted octanol/water partition coefficient (QPlogPo/w)3.378
Predicted aqueous solubility (QPlogS)-5.513
Conformation-independent predicted aqueous solubility (CIQPlogS)-6.476
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.904
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)137.185
Predicted brain/blood partition coefficient (QPlogBB)-2.13
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)57.794
Predicted skin permeability, log Kp (QPlogKp)-3.446
PM3 calculated ionization potential (IP(ev))8.729
PM3 calculated electron affinity (EA(eV))0.54
Number of likely metabolic reactions (#metab)7
Prediction of binding to human serum albumin (QPlogKhsa)0.382
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)84.976
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)137.965
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P13866SLC5A1Sodium/glucose cotransporter 1T54771SwissTargetPrediction
P17612PRKACAcAMP-dependent protein kinase alpha-catalytic subunitT12808SwissTargetPrediction
P05121SERPINE1Plasminogen activator inhibitor-1T15556SwissTargetPrediction
P24723PRKCHProtein kinase C etaT40149SwissTargetPrediction
P05771PRKCBProtein kinase C betaT40276SwissTargetPrediction
Q02156PRKCEProtein kinase C epsilonT00895SwissTargetPrediction
Q05655PRKCDProtein kinase C deltaT44861SwissTargetPrediction
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SwissTargetPrediction
P05129PRKCGProtein kinase C gammaT47107SwissTargetPrediction
P16152CBR1Carbonyl reductase [NADPH] 1T70518SwissTargetPrediction and SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
Q96HK3CALMCalmodulinT39610SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T54771DI0120Diabetes mellitus[ICD-11: 5A10]P13866SLC5A1
T54771DI0175Heart failure[ICD-11: BD10-BD1Z]P13866SLC5A1
T54771DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P13866SLC5A1
T12808DI0279Muscular atrophy[ICD-11: 8B61]P17612PRKACA
T15556DI0037Asthma[ICD-11: CA23]P05121SERPINE1
T15556DI0405Thrombosis[ICD-11: DB61-GB90]P05121SERPINE1
T40149DI0184Human immunodeficiency virus disease[ICD-11: 1C60-1C62]P24723PRKCH
T40276DI0123Diffuse large B-cell lymphoma[ICD-11: 2A81]P05771PRKCB
T40276DI0241Lymphoma[ICD-11: 2A80-2A86]P05771PRKCB
T40276DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]P05771PRKCB
T00895DI0033Anxiety disorder[ICD-11: 6B00-6B0Z]Q02156PRKCE
T00895DI0243Malaria[ICD-11: 1F40-1F45]Q02156PRKCE
T44861DI0287Myocardial infarction[ICD-11: BA41-BA43]Q05655PRKCD
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1
T47107DI0012Acute myeloid leukaemia[ICD-11: 2A60]P05129PRKCG
T47107DI0248Mastocytosis[ICD-11: 2A21]P05129PRKCG
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS
T39610DI0068Cardiac arrhythmia[ICD-11: BC9Z]Q96HK3CALM
T39610DI0243Malaria[ICD-11: 1F40-1F45]Q96HK3CALM
T39610DI0370Schizophrenia[ICD-11: 6A20]Q96HK3CALM

Copyright © 2025